Meta-research: Justifying career disruption in funding applications, a survey of Australian researchers

  1. Adrian Barnett  Is a corresponding author
  2. Katie Page
  3. Carly Dyer
  4. Susanna Cramb
  1. Queensland University of Technology, Australia
  2. University of Technology Sydney, Australia
  3. Queensland University of Technology, Australia

Abstract

Background: When researchers' careers are disrupted by life events-such as illness or childbirth-they often need to take extended time off. This creates a gap in their research output that can reduce their chances of winning funding. In Australia, applicants can disclose their career disruptions and peer reviewers are instructed to make appropriate adjustments. However, it is not clear if and how applicants use career disruption sections or how reviewers adjust and if they do it consistently.

Methods: To examine career disruption, we used surveys of the Australian health and medical research community. We used both a random sample of Australian authors on PubMed and a non-random convenience sample.

Results: Respondents expressed concerns that sharing information on career disruption would harm their chances of being funded, with 13% saying they have medical or social circumstances but would not include it in their application, with concerns about appearing 'weak'. Women were more reluctant to include disruption. There was inconsistency in how disruption was adjusted for, with less time given for those with depression compared with caring responsibilities, and less time given for those who did not provide medical details of their disruption.

Conclusions: The current system is likely not adequately adjusting for career disruption and this may help explain the ongoing funding gap for senior women in Australia.

Funding: National Health and Medical Research Council Senior Research Fellowship (Barnett).

Data availability

All data and code are openly available here https://github.com/agbarnett/career_disruption

The following data sets were generated

Article and author information

Author details

  1. Adrian Barnett

    School of Public Health and Social Work, Queensland University of Technology, Brisbane, Australia
    For correspondence
    a.barnett@qut.edu.au
    Competing interests
    Adrian Barnett, receives funding from the NHMRC and is a member of the NHMRC Research Committee..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6339-0374
  2. Katie Page

    Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia
    Competing interests
    No competing interests declared.
  3. Carly Dyer

    Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Australia
    Competing interests
    No competing interests declared.
  4. Susanna Cramb

    Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Australia
    Competing interests
    Susanna Cramb, receives funding from the NHMRC.

Funding

National Health and Medical Research Council (APP1117784)

  • Adrian Barnett

National Health and Medical Research Council (APP2008313)

  • Susanna Cramb

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Ethics approval was obtained from the Queensland University of Technology human research ethics committee. All participants provided informed consent before completing the survey.

Copyright

© 2022, Barnett et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,696
    views
  • 155
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Adrian Barnett
  2. Katie Page
  3. Carly Dyer
  4. Susanna Cramb
(2022)
Meta-research: Justifying career disruption in funding applications, a survey of Australian researchers
eLife 11:e76123.
https://doi.org/10.7554/eLife.76123

Share this article

https://doi.org/10.7554/eLife.76123

Further reading

    1. Medicine
    Hyun Beom Song, Laura Campello ... Anand Swaroop
    Research Advance

    Inherited retinal degenerations (IRDs) constitute a group of clinically and genetically diverse vision-impairing disorders. Retinitis pigmentosa (RP), the most common form of IRD, is characterized by gradual dysfunction and degeneration of rod photoreceptors, followed by the loss of cone photoreceptors. Recently, we identified reserpine as a lead molecule for maintaining rod survival in mouse and human retinal organoids as well as in the rd16 mouse, which phenocopy Leber congenital amaurosis caused by mutations in the cilia-centrosomal gene CEP290 (Chen et al., 2023). Here, we show the therapeutic potential of reserpine in a rhodopsin P23H rat model of autosomal dominant RP. At postnatal day (P) 68, when males and females are analyzed together, the reserpine-treated rats exhibit higher rod-derived scotopic b-wave amplitudes compared to the controls with little or no change in scotopic a-wave or cone-derived photopic b-wave. Interestingly, the reserpine-treated female rats display enhanced scotopic a- and b-waves and photopic b-wave responses at P68, along with a better contrast threshold and increased outer nuclear layer thickness. The female rats demonstrate better preservation of both rod and cone photoreceptors following reserpine treatment. Retinal transcriptome analysis reveals sex-specific responses to reserpine, with significant upregulation of phototransduction genes and proteostasis-related pathways, and notably, genes associated with stress response. This study builds upon our previously reported results reaffirming the potential of reserpine for gene-agnostic treatment of IRDs and emphasizes the importance of biological sex in retinal disease research and therapy development.

    1. Cell Biology
    2. Medicine
    Wadih EI Khoury, Stephen Y Chan
    Insight

    In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.